Nasal and exhaled nitric oxide in children and adolescents with HIV-1 infection
F. Santamaria, S. De Stefano, E. Bruzzese, A. Detoraki, S. Montella, F. Barbarano, A. Guarino (Naples, Italy)
Source: Annual Congress 2006 - Pneumonia and other invasive pulmonary infections in children
Disease area: Paediatric lung diseases
Abstract Nitric oxide (NO) is a component of the host defence against infections. Normal fractional exhaled NO (FENO ) and low nasal NO (nNO) have been demonstrated in HIV adults. FENO and nNO have never been measured in children with HIV infection. We measured FENO and nNO (ppb; NIOX, Aerocrine) in 30 children (19 females; median age: 10.7 yrs, range, 5.8-16 yrs) with perinatal HIV infection (median age at diagnosis: 1.5 yrs, range, 0.5-10 yrs). According to CDC criteria, 36.7% of patients were classified as class A, 43.3% as class B and 20% as class C. FVC and FEV1 (% pred), HIV mRNA (copies/ml) and CD4 absolute cells were measured. Recurrent rhinosinusitis (defined as 3 or more episodes of acute rhinosinusitis/year) or recurrent pneumonia (defined as at least 2 episodes in 1 year or > 3 at any time) were reported. Results are presented as mean ± SEM. FENO was 10.8 ppb ± 1.3 (values in healthy children according to Buchvald, 2005: 9.7 ppb). nNO was 161.2 ppb ± 26.3 (values in healthy children according to Struben, 2005: 449 ppb). FVC and FEV1 were 116. ± 3.9 and 114 ± 3.3 % pred, respectively. HIV RNA concentration and number of CD4 were 17063.67 ± 9256 copies/ml and 834.90 ± 61.6 cells/mm3 , respectively. Recurrent rhinosinusitis or pneumonia were found in 24 (80% of the total) and in 9 of 30 cases (30% of the total), respectively. Age appeared significantly related to FENO (r= 0.4; p = 0.03), and not to nNO (r= 0.08; p = 0.7). FENO and nNO were not related to CDC class, HIV RNA concentration or CD4 cells. nNO was significantly related to recurrent rhinosinusitis (r= 0.5; p = 0.02). We speculate that low nNO may contribute to the decreased resistance to upper airway infections in children with HIV infection.
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
F. Santamaria, S. De Stefano, E. Bruzzese, A. Detoraki, S. Montella, F. Barbarano, A. Guarino (Naples, Italy). Nasal and exhaled nitric oxide in children and adolescents with HIV-1 infection. Eur Respir J 2006; 28: Suppl. 50, 1787
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
Exhaled nitric oxide and airway resistance in preschool children with and without respiratory symptoms Source: Annual Congress 2008 - Wheezing in preschool children Year: 2008
Longitudinal changes in exhaled and nasal nitric oxide in children and young adults with asthma. Source: International Congress 2018 – Airway disease: recent discoveries Year: 2018
Exhaled nitric oxide in children with severe asthma Source: Annual Congress 2012 - Severe asthma and developing allergy in childhood Year: 2012
Exhaled nitric oxide distinguishes between subgroups of preschool children with respiratory symptoms Source: Annual Congress 2007 - Pathophysiology of childhood asthma: new insights Year: 2007
Measurement of exhaled nitric oxide in children Source: Guideline 2002 Year: 2002
Who are the children with increased faractional exhaled nitric oxide? Source: Virtual Congress 2020 – Paediatric asthma Year: 2020
Reproducibility of exhaled nitric oxide measurements in healthy and asthmatic adults and children Source: Eur Respir J 2003; 21: 433-438 Year: 2003
Exercise testing and exhaled nitric oxide levels in asthmatic children Source: Eur Respir J 2001; 18: Suppl. 33, 39s Year: 2001
Respiratory function tests and exhaled nitric oxide in asthmatic children Source: Eur Respir J 2004; 24: Suppl. 48, 270s Year: 2004
Atopy influences exhaled nitric oxide levels in healthy schoolchildren Source: Annual Congress 2007 - Epidemiology of paediatric asthma: genes, environment and prognosis Year: 2007
Exhaled nitric oxide (eNO): an early indicator of asthma relapse in children Source: Eur Respir J 2005; 26: Suppl. 49, 42s Year: 2005
Parental smoking increases exhaled nitric oxide in young children Source: Eur Respir J 2006 Oct 01;28(4):730-733 Year: 2006
Exhaled nitric oxide and pulmonary function tests in children with asthma Source: Eur Respir J 2007; 30: Suppl. 51, 759s Year: 2007
Fractional exhaled nitric oxide (FeNO ) in asthmatic children and their parents Source: Eur Respir J 2006; 28: Suppl. 50, 270s Year: 2006
Exhaled nitric oxide in children with OSAS Source: Eur Respir J 2001; 18: Suppl. 33, 90s Year: 2001
NO kidding: exhaled nitric oxide fraction in preschool children Source: Eur Respir J 2015; 45: 30-32 Year: 2015
The influence of spirometry on the level of exhaled nitric oxide in asthmatic children Source: Eur Respir J 2003; 22: Suppl. 45, 569s Year: 2003
Exhaled nitric oxide measurement in obese children Source: Eur Respir J 2007; 30: Suppl. 51, 724s Year: 2007
Nasal nitric oxide, exhaled nitric oxide and exhaled breath condensate pH measurements in children with allergic disease Source: Annual Congress 2008 - Clinical utility of exhaled nitric oxide measurement Year: 2008
Exhaled nitric oxide (eNO) as a noninvasive assessment of recurrent wheezers in school children Source: Eur Respir J 2003; 22: Suppl. 45, 569s Year: 2003